Empresa Oasmia Pharmaceutical AB NORDIC GROWTH MARKET
Acciones
OASM
SE0000722365
Farmacéuticos
Resumen de negocios
Ventas por región
SEK en millones | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
European Union
100,0
%
| - | - | 1 | 100,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 66 | 23/01/23 |
Robert Maiorana
DFI | Director of Finance/CFO | 64 | 01/12/20 |
Heidi Ramstad
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/21 |
Johanna Röstin
LAW | General Counsel | 57 | 01/10/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chairman | 44 | 19/03/19 | |
Hege Hellstrom
BRD | Director/Board Member | 59 | 26/09/19 |
Pål Ryfors
BRD | Director/Board Member | 41 | 25/05/22 |
Roger Tell
BRD | Director/Board Member | 59 | 25/05/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 538 043 455 | 330 469 658 ( 61,42 %) | 0 | 61,42 % |
Información de la empresa
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+31,28 % | 588 mil M | |
-3,42 % | 364 mil M | |
+18,02 % | 326 mil M | |
+4,27 % | 285 mil M | |
+14,75 % | 239 mil M | |
+10,25 % | 210 mil M | |
-6,95 % | 200 mil M | |
+8,12 % | 167 mil M | |
-1,42 % | 161 mil M |